190 related articles for article (PubMed ID: 35109724)
1. Systematic review of pharmacological interventions for people with Lewy body dementia.
Watts KE; Storr NJ; Barr PG; Rajkumar AP
Aging Ment Health; 2023 Feb; 27(2):203-216. PubMed ID: 35109724
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
3. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study.
Chiu PY; Tsai CT; Chen PK; Chen WJ; Lai TJ
PLoS One; 2016; 11(4):e0153989. PubMed ID: 27101140
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
[TBL] [Abstract][Full Text] [Related]
6. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
Drach LM
Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
[TBL] [Abstract][Full Text] [Related]
7. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
[TBL] [Abstract][Full Text] [Related]
8. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
Stinton C; McKeith I; Taylor JP; Lafortune L; Mioshi E; Mak E; Cambridge V; Mason J; Thomas A; O'Brien JT
Am J Psychiatry; 2015 Aug; 172(8):731-42. PubMed ID: 26085043
[TBL] [Abstract][Full Text] [Related]
10. Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease.
Varanese S; Perfetti B; Monaco D; Thomas A; Bonanni L; Tiraboschi P; Onofrj M
J Neurol; 2010 Jun; 257(6):1004-11. PubMed ID: 20094726
[TBL] [Abstract][Full Text] [Related]
11. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
12. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
13. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
14. No Significant Difference in Cognitive Decline and Mortality between Parkinson's Disease Dementia and Dementia with Lewy Bodies: Naturalistic Longitudinal Data from the Swedish Dementia Registry.
Fereshtehnejad SM; Lökk J; Wimo A; Eriksdotter M
J Parkinsons Dis; 2018; 8(4):553-561. PubMed ID: 30103351
[TBL] [Abstract][Full Text] [Related]
15. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
[TBL] [Abstract][Full Text] [Related]
16. Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis.
Wong YY; Wu CY; Yu D; Kim E; Wong M; Elez R; Zebarth J; Ouk M; Tan J; Liao J; Haydarian E; Li S; Fang Y; Li P; Pakosh M; Tartaglia MC; Masellis M; Swardfager W
Parkinsonism Relat Disord; 2022 Aug; 101():119-128. PubMed ID: 35760718
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.
Aarsland D; Ballard C; Rongve A; Broadstock M; Svenningsson P
Curr Neurol Neurosci Rep; 2012 Oct; 12(5):492-501. PubMed ID: 22806065
[TBL] [Abstract][Full Text] [Related]
18. Treatment of dementia with Lewy bodies and Parkinson's disease dementia.
Ballard C; Kahn Z; Corbett A
Drugs Aging; 2011 Oct; 28(10):769-77. PubMed ID: 21970305
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
[TBL] [Abstract][Full Text] [Related]
20. Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update.
MacDonald S; Shah AS; Tousi B
Drugs Aging; 2022 Jul; 39(7):505-522. PubMed ID: 35619045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
